Research - Calgary, Alberta, Canada
Trucelium is a vertically integrated mushroom health company. Our united philosophy is taking the best of Eastern Medicine and merging it with the best of Western Medicine in unique, proprietary ways.The company has a 3 phase launch of horizontally integrated streams:1) Phase 1 - Nutraceutical Mushrooms (legal)2) Phase 2 - Psychedelics IP3) Phase 3 - Bioavailability EnhancementFirst Focused Priority - Launching the nutraceutical mushroom business to address the massive supply gap in the North American nutraceutical mushroom powder market. We will grow the 8 market dominating species including: Cordyceps, Reishi, Lion's Mane, Turkey Tail, Shiitake, Maitake, Almond Mushroom, and Chaga.We have already secured $16M in customer LOIs for nutraceutical mushroom powder sales. With all this customer traction, we may consider launching our second facility in 2025. If this were to occur, Series A investors could experience a 15x multiplier by 2026 on nutraceutical revenues alone. This does not factor in the exciting opportunities we have in psychedelic & bioavailability markets, expected to generate further revenues via licensing. Trucelum's leadership team is composed of global leaders in targeted industries that have exceptional value to the domain we intend to occupy, and has extensive experience successfully launching companies from the early startup phase through to high growth profile.Upon execution of an NDA we can then walk you through in greater detail both the opportunity and the disruptive patents we have filed that will position us for technology licensing and profitable exits ranging from M&As to IPOs.
Gmail
WordPress.org
Gravity Forms
Mobile Friendly
Google Cloud Hosting